|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61P 3/00 | (2006.01) |
| A61P 7/00 | (2006.01) | ||
| A61P 9/00 | (2006.01) | ||
| A61P 25/28 | (2006.01) | ||
| A61P 43/00 | (2006.01) | ||
| C07K 16/40 | (2006.01) | ||
| A61P 3/06 | (2006.01) | ||
| A61K 39/395 | (2006.01) | ||
| A61K 45/06 | (2006.01) | ||
| A61K 31/22 | (2006.01) | ||
| A61K 31/366 | (2006.01) | ||
| A61K 31/40 | (2006.01) | ||
| A61K 31/405 | (2006.01) | ||
| A61K 31/44 | (2006.01) | ||
| A61K 31/47 | (2006.01) | ||
| A61K 31/505 | (2006.01) | ||
| A61K 31/66 | (2006.01) | ||
| A61K 39/00 | (2006.01) | ||
| C12N 15/115 | (2010.01) | ||
| A61P 9/10 | (2006.01) |
| (11) | Number of the document | 2215124 |
| (13) | Kind of document | T |
| (96) | European patent application number | 08798550.3 |
| Date of filing the European patent application | 2008-08-22 | |
| (97) | Date of publication of the European application | 2010-08-11 |
| (45) | Date of publication and mention of the grant of the patent | 2016-02-24 |
| (46) | Date of publication of the claims translation | 2016-06-10 |
| (86) | Number | PCT/US2008/074097 |
| Date | 2008-08-22 |
| (87) | Number | WO 2009/026558 |
| Date | 2009-02-26 |
| (30) | Number | Date | Country code |
| 10630 P | 2008-01-09 | US | |
| 86133 P | 2008-08-04 | US | |
| 957668 P | 2007-08-23 | US | |
| 8965 P | 2007-12-21 | US |
| (72) |
JACKSON, Simon, Mark, US
WALKER, Nigel Pelham, Clinton, US
PIPER, Derek, Evan, US
SHAN, Bei, US
SHEN, Wenyan, US
CHAN, Joyce Chi, Yee, US
KING, Chadwick, Terence, CA
KETCHEM, Randal, Robert, US
MEHLIN, Christopher, US
CARABEO, Teresa, Arazas, US
CAO, Qiong, US
|
| (73) |
Amgen Inc.,
One Amgen Center Drive, Thousand Oaks, CA 91320-1799,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Antigeną surišantys baltymai prieš subtilizino/keksino tipo 9 proproteino konvertazę (PCSK9) |
| ANTIGEN BINDING PROTEINS TO PROPROTEIN CONVERTASE SUBTILISIN KEXIN TYPE 9 (PCSK9) |
| Payment date | Validity (years) | Amount | |
| 2025-07-23 | 18 | 347.00 EUR |
| 2026-08-22 |